Current Affairs - National - Discussion

Discussion Forum : National - Latest Current Affairs (Q.No. 4546)
4546.
The National Task Force on COVID-19 recently decided against using which drug in clinical management protocols?
Itolizumab
Chloroquine
Favilavir
Fusogenix
Answer: Option
Explanation:
The National Task Force on COVID-19 recently decided against using Itolizumab in clinical management protocols. The Drugs Controller General of India (DCGI) had earlier approved for "restricted emergency use" of the drug.
Discussion:
Be the first person to comment on this question !

Post your comments here:

Your comments will be displayed after verification.